Genetic Analysis AS (NGM:GEAN)
Sweden
· Delayed Price · Currency is SEK · Price in NOK 1.030
-0.020 (-1.90%)
At close: Jun 12, 2025
Genetic Analysis AS Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Operating Revenue | 14.99 | 15.89 | 14.15 | 11.16 | 6.8 | 5.78 | Upgrade
|
| Other Revenue | 4.93 | 4.8 | 9.02 | 9.58 | 6.58 | 1.76 | Upgrade
|
| Revenue | 19.93 | 20.68 | 23.16 | 20.75 | 13.38 | 7.54 | Upgrade
|
| Revenue Growth (YoY) | -7.64% | -10.71% | 11.65% | 55.08% | 77.51% | -31.81% | Upgrade
|
| Cost of Revenue | 2.95 | 3.32 | 4.6 | 3.91 | 1.28 | 1.03 | Upgrade
|
| Gross Profit | 16.98 | 17.36 | 18.57 | 16.84 | 12.1 | 6.51 | Upgrade
|
| Selling, General & Admin | 16.21 | 16.83 | 20.72 | 22.31 | 20.39 | 14.68 | Upgrade
|
| Other Operating Expenses | 8.97 | 9.78 | 16.23 | 17.88 | 16.05 | 7.8 | Upgrade
|
| Operating Expenses | 30.46 | 31.85 | 42.52 | 45.02 | 40.97 | 27.28 | Upgrade
|
| Operating Income | -13.48 | -14.49 | -23.96 | -28.18 | -28.87 | -20.77 | Upgrade
|
| Interest Expense | -0.12 | -0.36 | -0.25 | -0.12 | -0.13 | -0.21 | Upgrade
|
| Interest & Investment Income | 0.39 | 0.42 | 0.36 | 0.03 | - | 0.03 | Upgrade
|
| Earnings From Equity Investments | -0.62 | -0.62 | -0.09 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.27 | 0.27 | 0.03 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | -0 | 0.09 | -0 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -13.55 | -14.77 | -23.82 | -28.27 | -29.01 | -20.95 | Upgrade
|
| Asset Writedown | - | - | - | - | - | -1.4 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 0.22 | Upgrade
|
| Pretax Income | -13.55 | -14.77 | -23.82 | -28.27 | -29.01 | -22.14 | Upgrade
|
| Net Income | -13.55 | -14.77 | -23.82 | -28.27 | -29.01 | -22.14 | Upgrade
|
| Net Income to Common | -13.55 | -14.77 | -23.82 | -28.27 | -29.01 | -22.14 | Upgrade
|
| Shares Outstanding (Basic) | 47 | 45 | 26 | 25 | 25 | 17 | Upgrade
|
| Shares Outstanding (Diluted) | 47 | 45 | 26 | 25 | 25 | 17 | Upgrade
|
| Shares Change (YoY) | 53.63% | 70.99% | 4.61% | 0.07% | 45.72% | 49.90% | Upgrade
|
| EPS (Basic) | -0.29 | -0.33 | -0.91 | -1.13 | -1.16 | -1.29 | Upgrade
|
| EPS (Diluted) | -0.29 | -0.33 | -0.91 | -1.13 | -1.16 | -1.29 | Upgrade
|
| Free Cash Flow | -6.26 | -8.96 | -17.38 | -19.69 | -27.7 | -6.58 | Upgrade
|
| Free Cash Flow Per Share | -0.13 | -0.20 | -0.66 | -0.79 | -1.11 | -0.38 | Upgrade
|
| Gross Margin | 85.22% | 83.93% | 80.15% | 81.17% | 90.42% | 86.37% | Upgrade
|
| Operating Margin | -67.64% | -70.03% | -103.41% | -135.84% | -215.80% | -275.56% | Upgrade
|
| Profit Margin | -68.02% | -71.40% | -102.82% | -136.28% | -216.80% | -293.70% | Upgrade
|
| Free Cash Flow Margin | -31.41% | -43.29% | -75.02% | -94.88% | -207.07% | -87.30% | Upgrade
|
| EBITDA | -13.19 | -14.24 | -23.77 | -28 | -28.7 | -20.57 | Upgrade
|
| EBITDA Margin | -66.22% | -68.82% | -102.61% | -134.95% | -214.56% | -273.00% | Upgrade
|
| D&A For EBITDA | 0.29 | 0.25 | 0.19 | 0.19 | 0.17 | 0.19 | Upgrade
|
| EBIT | -13.48 | -14.49 | -23.96 | -28.18 | -28.87 | -20.77 | Upgrade
|
| EBIT Margin | -67.64% | -70.03% | -103.41% | -135.84% | -215.80% | -275.56% | Upgrade
|
| Revenue as Reported | 19.93 | 20.68 | 23.16 | 20.75 | 13.38 | 7.75 | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.